Skip to content
Sign in
Business opportunities for Amass Biosystems

Why talk

  • Amass Biosystems likely needs funding for the next round — ZymoChem (United States, Series A, $25M raised) can offer investor introductions (inferred from public profile).
  • Complementary sectors: Agri & FoodTech × Biotech & life sciences — room for a joint offer or co-selling.
  • ZymoChem has raised about $25M — investor introductions are realistic.

Score by goal: All goals 48 · Market entry 46 · Customers 35 · Investment 65 · Peers 41

Dimension by dimension

Needs ↔ offers

17.5 / 35 pts

ZymoChem can help Amass Biosystems.

  • Amass Biosystems likely needs funding for the next round — ZymoChem (United States, Series A, $25M raised) can offer investor introductions (inferred from public profile).

Market bridge

8.8 / 25 pts

Distant markets.

  • Both are based in United States: shared local customers, investors and ecosystem.

Customer potential

0.0 / 15 pts

Neither side has a product on the market yet.

Sector synergy

12.8 / 15 pts

Complementary sectors.

  • Complementary sectors: Agri & FoodTech × Biotech & life sciences — room for a joint offer or co-selling.

Stage complementarity

9.0 / 10 pts

Strong mentoring / investor-intro potential.

  • ZymoChem has raised about $25M — investor introductions are realistic.
  • ZymoChem (Series A) is well ahead of Amass Biosystems (Pre-seed): mentoring and investor intros.

How the score works

Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “All goals”: Needs ↔ offers 35, Market bridge 25, Customer potential 15, Sector synergy 15, Stage complementarity 10. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.

Potential blends compatibility (65%) with the mean global score of both startups (35%): 47/100 — high from 50, medium from 36.